174 related articles for article (PubMed ID: 15276714)
1. Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.
White IN; Brown K
Trends Pharmacol Sci; 2004 Aug; 25(8):442-7. PubMed ID: 15276714
[TBL] [Abstract][Full Text] [Related]
2. Applications of accelerator mass spectrometry for pharmacological and toxicological research.
Brown K; Tompkins EM; White IN
Mass Spectrom Rev; 2006; 25(1):127-45. PubMed ID: 16059873
[TBL] [Abstract][Full Text] [Related]
3. Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research.
Turteltaub KW; Vogel JS
Curr Pharm Des; 2000 Jul; 6(10):991-1007. PubMed ID: 10828298
[TBL] [Abstract][Full Text] [Related]
4. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
Barker J; Garner RC
Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404
[TBL] [Abstract][Full Text] [Related]
5. Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.
Dingley KH; Roberts ML; Velsko CA; Turteltaub KW
Chem Res Toxicol; 1998 Oct; 11(10):1217-22. PubMed ID: 9778319
[TBL] [Abstract][Full Text] [Related]
6. Accelerator mass spectrometry.
Hellborg R; Skog G
Mass Spectrom Rev; 2008; 27(5):398-427. PubMed ID: 18470926
[TBL] [Abstract][Full Text] [Related]
7. Neuroscience and accelerator mass spectrometry.
Palmblad M; Buchholz BA; Hillegonds DJ; Vogel JS
J Mass Spectrom; 2005 Feb; 40(2):154-9. PubMed ID: 15706618
[TBL] [Abstract][Full Text] [Related]
8. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
Turteltaub KW; Vogel JS; Frantz CE; Fultz E
IARC Sci Publ; 1993; (124):293-301. PubMed ID: 8225498
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the DNA adduction and pharmacokinetics of PhIP and MeIOx in rodents at doses approximating human exposure using the technique of accelerator mass spectrometry (AMS) and 32P-postlabeling.
Turteltaub KW; Vogel JS; Frantz C; Felton JS; McManus M
Princess Takamatsu Symp; 1995; 23():93-102. PubMed ID: 8844800
[TBL] [Abstract][Full Text] [Related]
10. Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometry.
Lappin G; Seymour M
Bioanalysis; 2010 Jul; 2(7):1315-24. PubMed ID: 21083242
[TBL] [Abstract][Full Text] [Related]
11. Screening for pharmaco-toxicologically relevant compounds in biosamples using high-resolution mass spectrometry: a 'metabolomic' approach to the discrimination between isomers.
Liotta E; Gottardo R; Bertaso A; Polettini A
J Mass Spectrom; 2010 Mar; 45(3):261-71. PubMed ID: 20014151
[TBL] [Abstract][Full Text] [Related]
12. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
Chung IM; Kim SH
Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in biomedical applications of accelerator mass spectrometry.
Hah SS; Henderson PT; Turteltaub KW
J Biomed Sci; 2009 Jun; 16(1):54. PubMed ID: 19534792
[TBL] [Abstract][Full Text] [Related]
14. Use of accelerator mass spectrometry for studies in nutrition.
Jackson GS; Weaver C; Elmore D
Nutr Res Rev; 2001 Dec; 14(2):317-34. PubMed ID: 19087429
[TBL] [Abstract][Full Text] [Related]
15. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
Turteltaub KW; Felton JS; Gledhill BL; Vogel JS; Southon JR; Caffee MW; Finkel RC; Nelson DE; Proctor ID; Davis JC
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5288-92. PubMed ID: 2371271
[TBL] [Abstract][Full Text] [Related]
16. Accelerator mass spectrometry for biomedical research.
Brown K; Dingley KH; Turteltaub KW
Methods Enzymol; 2005; 402():423-43. PubMed ID: 16401518
[TBL] [Abstract][Full Text] [Related]
17. DNA adducts: mass spectrometry methods and future prospects.
Farmer PB; Brown K; Tompkins E; Emms VL; Jones DJ; Singh R; Phillips DH
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):293-301. PubMed ID: 15990134
[TBL] [Abstract][Full Text] [Related]
18. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation.
Rickert DE; Dingley K; Ubick E; Dix KJ; Molina L
Chem Biol Interact; 2005 Jun; 155(1-2):55-61. PubMed ID: 15893299
[TBL] [Abstract][Full Text] [Related]
19. Microdose study of 14C-acetaminophen with accelerator mass spectrometry to examine pharmacokinetics of parent drug and metabolites in healthy subjects.
Tozuka Z; Kusuhara H; Nozawa K; Hamabe Y; Ikushima I; Ikeda T; Sugiyama Y
Clin Pharmacol Ther; 2010 Dec; 88(6):824-30. PubMed ID: 21048707
[TBL] [Abstract][Full Text] [Related]
20. Effective determination of the long-lived nuclide 41Ca in nuclear reactor bioshield concretes: comparison of liquid scintillation counting and accelerator mass spectrometry.
Warwick PE; Croudace IW; Hillegonds DJ
Anal Chem; 2009 Mar; 81(5):1901-6. PubMed ID: 19178149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
